Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Lundbeck at Biomarkers Europe 2026

Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website

Lundbeck takes part in 4 sessions at Biomarkers Europe 2026 in Basel. Its sessions centre on precision medicine for brain diseases and on moving biomarkers from discovery into clinical use. They focus on how biomarkers can steer decisions in developing treatments for neurodegenerative diseases.

OrganizationBiomarkers Europe 2026 Attendance
Lundbeck
Copenhagen, Denmark
Large pharma
Danish pharmaceutical company focused on brain diseases, with medicines in psychiatry, neurology and migraine.
Talk
Tue Oct 13
8:45am–9:15am
New Frontiers In Precision Medicine – The Neurology Example
Biomarker discovery & translation
Panel
Tue Oct 13
1:05pm–1:30pm
Translating Biomarkers From Discovery To Clinical Use
with Step Pharma, Monte Rosa Therapeutics, Humanitas Research Hospital +2 more
Biomarker discovery & translation
Panel
Wed Oct 14
1:00pm–1:30pm
Biomarker Strategies In Neurodegenerative Therapeutics
with Cure Parkinson's, Neuro-Bio, Novo Nordisk +2 more
Biomarker discovery & translation
Talk
Wed Oct 14
4:05pm–4:30pm
Using Biomarkers To Drive Decision-Making In Neurodegenerative Diseases
Biomarker discovery & translation

Explore the full Biomarkers Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Biomarkers Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Lundbeck

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction